(BIBL) Northern Lights Fund Trust - Overview
Etf: Stocks, Us, Large-Cap, Faith-Based, Equity
Dividends
| Dividend Yield | 1.09% |
| Yield on Cost 5y | 1.47% |
| Yield CAGR 5y | -49.58% |
| Payout Consistency | 83.8% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 16.1% |
| Relative Tail Risk | 2.18% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.79 |
| Alpha | 4.76 |
| Character TTM | |
|---|---|
| Beta | 0.970 |
| Beta Downside | 0.982 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.60% |
| CAGR/Max DD | 0.79 |
Description: BIBL Northern Lights Fund Trust December 30, 2025
The Northern Lights Fund Trust IV – Inspire 100 ETF (NYSE ARCA:BIBL) seeks to allocate at least 80 % of its net assets to the securities comprising the Inspire 100 Index, which screens U.S. large-cap equities through the proprietary Inspire Impact Score®. That score quantifies each company’s alignment with biblical-based values and its positive impact on customers, communities, employees, and broader society.
As of the most recent filing (Q3 2024), BIBL holds roughly 95 % of its assets in the top 100 constituents, with an expense ratio of 0.65 % and an average market-cap weighting of $12 billion. The ETF’s sector tilt leans toward technology (≈30 % of assets) and consumer discretionary (≈25 %), both of which have benefited from the post-pandemic acceleration in digital adoption and discretionary spending. Key performance indicators to watch include the fund’s turnover ratio (≈45 % annualized) and the underlying Impact Score average (≈78 out of 100), which together signal both portfolio stability and adherence to the impact criteria.
For a deeper, data-driven view of BIBL’s risk-adjusted returns and impact metrics, you may find ValueRay’s interactive analytics platform useful for independent research.
What is the price of BIBL shares?
Over the past week, the price has changed by +1.95%, over one month by +5.92%, over three months by +8.58% and over the past year by +19.31%.
Is BIBL a buy, sell or hold?
What are the forecasts/targets for the BIBL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 55.2 | 12.5% |
BIBL Fundamental Data Overview February 09, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 385.0m USD (385.0m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 385.0m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 385.0m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.49% (E(385.0m)/V(385.0m) * Re(9.49%) + (debt-free company))
Discount Rate = 9.49% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)